Home / SH3BGRL Knockout Cell Lines

SH3BGRL Knockout Cell Lines

Gene: SH3BGRL

Official Full Name: SH3 domain binding glutamate rich protein likeprovided by HGNC

Gene Summary: Enables protein-RNA adaptor activity and ubiquitin-like ligase-substrate adaptor activity. Involved in positive regulation of cytoplasmic translational initiation and proteasome-mediated ubiquitin-dependent protein catabolic process. Located in cytosol. [provided by Alliance of Genome Resources, Apr 2025]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO35457 SH3BGRL Knockout cell line (HeLa) Human SH3BGRL 1:3~1:6 Negative Online Inquiry
KO35458 SH3BGRL Knockout cell line (HCT 116) Human SH3BGRL 1:2~1:4 Negative Online Inquiry
KO35459 SH3BGRL Knockout cell line (HEK293) Human SH3BGRL 1:3~1:6 Negative Online Inquiry
KO35460 SH3BGRL Knockout cell line (A549) Human SH3BGRL 1:3~1:4 Negative Online Inquiry

Background

SH3BGRL Gene Knockout Cell Lines are genetically modified cell lines specifically designed to lack the SH3BGRL gene, which encodes for the SH3 domain binding glutamic acid-rich protein-like isoforms. These cell lines serve as powerful tools for researchers seeking to elucidate the biological functions associated with the SH3BGRL gene, particularly its role in cell signaling, cytoskeletal organization, and various cellular processes linked to proliferation and apoptosis.

The key function of these knockout cell lines is to enable the study of gene function through a loss-of-function approach. By systematically eliminating the SH3BGRL gene, researchers can observe phenotypic changes at the cellular level, gain insights into the molecular pathways affected, and understand any compensatory mechanisms that may arise in the absence of this gene. The knockouts are created using precise CRISPR-Cas9 technology, ensuring high specificity and efficiency in gene editing.

Scientifically, SH3BGRL Gene Knockout Cell Lines are crucial for a myriad of applications, from basic research investigating the role of SH3 domain proteins to potential clinical implications in understanding diseases where this gene may play a contributory role, including cancer and neurodegenerative disorders. Their availability allows for the exploration of novel therapeutic avenues targeting related pathways.

Compared to conventional methods of gene silencing, such as RNA interference, these knockout cell lines provide a more stable and permanent gene editing tool that allows long-term studies without the transient effects often observed with siRNA. This stability is a significant advantage for experimental reproducibility and the generation of reliable data.

For researchers and clinicians alike, the SH3BGRL Gene Knockout Cell Lines represent a pivotal asset, enabling them to advance their investigations into protein function and disease mechanisms with confidence. Our company, equipped with advanced gene editing technologies and a deep understanding of cellular biology, is committed to providing high-quality biological products that empower scientific discovery and innovation.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.